Alkermes plc ALKS

NAS: ALKS | ISIN: IE00B56GVS15 19/12/2025

28,45 USD (+2,30%)

(+2,30%) 19/12/2025

Grafiek Alkermes plc

Grafiek Alkermes plc

1 dag1d 2,30%
1 week1w 1,39%
1 maand1m 0,89%
3 maanden3m 2,52%
6 maanden6m -2,77%
1 jaar1j -3,56%
5 jaar5j 33,82%

Alkermes plc in het nieuws

Toon enkel gratis nieuws

19 november 2025 · Alkermes plc Announces Increased Offer to Acquire Avadel Pharmaceuticals plc · Persbericht

14 november 2025 · Alkermes Response to Avadel Announcement · Persbericht

12 november 2025 · Alkermes Announces Positive Topline Results From Vibrance-2 Phase 2 Study of Once-Daily Alixorexton in Patients With Narcolepsy Type 2 · Persbericht

6 november 2025 · Alkermes to Participate in Two Upcoming Investor Conferences · Persbericht

5 november 2025 · FORM 8.1(a) & (b) (Opening Position Disclosure) · Persbericht

28 oktober 2025 · Alkermes plc Reports Third Quarter 2025 Financial Results · Persbericht

22 oktober 2025 · Alkermes plc Announces Agreement to Acquire Avadel Pharmaceuticals plc · Persbericht

20 oktober 2025 · Alkermes to Report Third Quarter Financial Results on October 28, 2025 · Persbericht

12 september 2025 · Alkermes Appoints Joshua Reed as Chief Financial Officer · Persbericht

11 september 2025 · Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program · Persbericht

Profiel Alkermes plc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe